Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Resveratrol given intraperitoneally does not inhibit the growth of high-risk t(4;11) acute lymphoblastic leukemia cells in a NOD/SCID mouse model.

Zunino SJ, Storms DH, Newman JW, Pedersen TL, Keen CL, Ducore JM.

Int J Oncol. 2012 Apr;40(4):1277-84. doi: 10.3892/ijo.2011.1316. Epub 2011 Dec 22.

2.

Dietary resveratrol does not delay engraftment, sensitize to vincristine or inhibit growth of high-risk acute lymphoblastic leukemia cells in NOD/SCID mice.

Zunino SJ, Storms DH, Newman JW, Pedersen TL, Keen CL, Ducore JM.

Int J Oncol. 2012 Dec;41(6):2207-12. doi: 10.3892/ijo.2012.1650. Epub 2012 Oct 4.

3.

Oral or parenteral administration of curcumin does not prevent the growth of high-risk t(4;11) acute lymphoblastic leukemia cells engrafted into a NOD/SCID mouse model.

Zunino SJ, Storms DH, Newman JW, Pedersen TL, Keen CL, Ducore JM.

Int J Oncol. 2013 Feb;42(2):741-8. doi: 10.3892/ijo.2012.1734. Epub 2012 Dec 12.

4.

Novel in vivo model of inducible multi-drug resistance in acute lymphoblastic leukemia with chromosomal translocation t(4;11).

Zunino SJ, Storms DH, Ducore JM.

Cancer Lett. 2010 Oct 1;296(1):49-54. doi: 10.1016/j.canlet.2010.03.017. Epub 2010 Apr 9.

5.
6.

Human acute leukemia cells injected in NOD/LtSz-scid/IL-2Rgamma null mice generate a faster and more efficient disease compared to other NOD/scid-related strains.

Agliano A, Martin-Padura I, Mancuso P, Marighetti P, Rabascio C, Pruneri G, Shultz LD, Bertolini F.

Int J Cancer. 2008 Nov 1;123(9):2222-7. doi: 10.1002/ijc.23772.

8.
9.

Resveratrol (trans-3,5,4'-trihydroxystilbene) suppresses EL4 tumor growth by induction of apoptosis involving reciprocal regulation of SIRT1 and NF-κB.

Singh NP, Singh UP, Hegde VL, Guan H, Hofseth L, Nagarkatti M, Nagarkatti PS.

Mol Nutr Food Res. 2011 Aug;55(8):1207-18. doi: 10.1002/mnfr.201000576. Epub 2011 Apr 26.

10.

[Establishment of human acute B-lymphoblastic leukemia NOD/SCID/IL2 receptor γ chain(null) neonatal mouse xenotransplant model].

Kong Y, Liu YR, Liu KY, Huang XJ, Ishikawa F, Harada M.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2012 Jun;20(3):762-8. Chinese.

PMID:
22739198
11.

[Establishment of Human Acute B-Lymphoblastic Leukemia--NOD/SCID Xenotransplant Mouse Model].

Zhang X, Deng Y, Chen FL, Fang YJ, Zhang W, Yu L.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2015 Jun;23(3):623-6. doi: 10.7534/j.issn.1009-2137.2015.03.004. Chinese.

PMID:
26117005
12.

Establishment of reproducible xenotransplantation model of T cell acute lymphoblastic leukemia in NOD/SCID mice.

Wang D, Wang N, Zhang Y, Ma S, Geng Z, Zhou P, Zhou J, Huang L.

J Huazhong Univ Sci Technolog Med Sci. 2012 Aug;32(4):511-6. doi: 10.1007/s11596-012-0088-5. Epub 2012 Aug 11.

PMID:
22886962
13.

miR-196b/miR-1290 participate in the antitumor effect of resveratrol via regulation of IGFBP3 expression in acute lymphoblastic leukemia.

Zhou W, Wang S, Ying Y, Zhou R, Mao P.

Oncol Rep. 2017 Feb;37(2):1075-1083. doi: 10.3892/or.2016.5321. Epub 2016 Dec 15.

PMID:
28000876
14.

Time--and Concentration--Dependent Effects of Resveratrol on miR 15a and miR16-1 Expression and Apoptosis in the CCRF-CEM Acute Lymphoblastic Leukemia Cell Line.

Azimi A, Hagh MF, Talebi M, Yousefi B, Hossein pour feizi AA, Baradaran B, Movassaghpour AA, Shamsasenjan K, Khanzedeh T, Ghaderi AH, Heydarabad MZ.

Asian Pac J Cancer Prev. 2015;16(15):6463-8.

15.

IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.

Phillips KE, Herring B, Wilson LA, Rickford MS, Zhang M, Goldman CK, Tso JY, Waldmann TA.

Cancer Res. 2000 Dec 15;60(24):6977-84.

16.

Plerixafor (AMD3100) induces prolonged mobilization of acute lymphoblastic leukemia cells and increases the proportion of cycling cells in the blood in mice.

Welschinger R, Liedtke F, Basnett J, Dela Pena A, Juarez JG, Bradstock KF, Bendall LJ.

Exp Hematol. 2013 Mar;41(3):293-302.e1. doi: 10.1016/j.exphem.2012.11.004. Epub 2012 Nov 23.

PMID:
23178377
17.

Monitoring of engraftment and progression of acute lymphoblastic leukemia in individual NOD/SCID mice.

Nijmeijer BA, Mollevanger P, van Zelderen-Bhola SL, Kluin-Nelemans HC, Willemze R, Falkenburg JH.

Exp Hematol. 2001 Mar;29(3):322-9.

PMID:
11274760
18.

Activity of resveratrol triesters against primary acute lymphoblastic leukemia cells.

Urbaniak A, Delgado M, Kacprzak K, Chambers TC.

Bioorg Med Chem Lett. 2017 Jun 15;27(12):2766-2770. doi: 10.1016/j.bmcl.2017.04.066. Epub 2017 May 9.

PMID:
28499732
19.

A human acute lymphoblastic leukemia line with the T(4;11) translocation as a model of minimal residual disease in SCID mice.

Gobbi A, Di Berardino C, Scanziani E, Garofalo A, Rivolta A, Fontana G, Rambaldi A, Giavazzi R, Biondi A.

Leuk Res. 1997 Nov-Dec;21(11-12):1107-14.

PMID:
9444945
20.

Resveratrol induces apoptosis and autophagy in T-cell acute lymphoblastic leukemia cells by inhibiting Akt/mTOR and activating p38-MAPK.

Ge J, Liu Y, Li Q, Guo X, Gu L, Ma ZG, Zhu YP.

Biomed Environ Sci. 2013 Nov;26(11):902-11. doi: 10.3967/bes2013.019.

Supplemental Content

Support Center